KURA ONCOLOGY, INC. Current Assets
KURA ONCOLOGY, INC. (KURA) had Current Assets of $559.44 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-12
- 2026-06-30: Assets, Current $559.44M.
- 2026-03-31: Assets, Current $623.78M.
- 2025-12-31: Assets, Current $708.66M.
- 2025-09-30: Assets, Current $620.66M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $559.44M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $623.78M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $708.66M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $620.66M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $660.08M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $724.20M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $744.83M 10-K · filed 2026-03-05 |
| 2024-09-30 | $463.19M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $499.77M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $537.84M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $432.48M 10-K · filed 2025-02-28 |
| 2023-09-30 | $459.92M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $485.65M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $416.45M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $446.43M 10-K · filed 2024-02-27 |
| 2022-09-30 | $436.39M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $459.79M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $487.03M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $522.29M 10-K · filed 2023-02-23 |
| 2021-09-30 | $548.90M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $573.63M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $610.71M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $637.29M 10-K · filed 2022-02-24 |
| 2020-09-30 | $328.91M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $342.19M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $221.13M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $239.60M 10-K · filed 2021-02-24 |
| 2019-09-30 | $252.95M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $263.90M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $167.59M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $181.20M 10-K · filed 2020-02-25 |
| 2018-09-30 | $190.39M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $128.53M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $140.36M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $94.64M 10-K · filed 2019-03-05 |
| 2017-09-30 | $101.92M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $54.73M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $60.63M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $68.81M 10-K · filed 2018-03-12 |
| 2016-09-30 | $75.72M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $81.42M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $80.08M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $86.87M 10-K · filed 2017-03-14 |
| 2015-09-30 | $42.31M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $47.19M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $54.63M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $1.20M 10-K · filed 2016-03-17 |
| 2013-03-31 | $4.03K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $8.30K 10-Q · filed 2013-05-15 |
| 2012-09-30 | $11.46K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $15.73K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $24.37K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $6.72K 10-K · filed 2013-03-28 |
| 2011-09-30 | $10.53K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $15.51K 10-Q · filed 2011-08-15 |
| 2011-03-31 | $6.72K 10-Q · filed 2012-05-15 |
| 2010-12-31 | $29.40K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |